Scholars Central

Conference abstractPublished 24 Nov 2016

Towards the development of a Zika virus vaccine

Authors: Tony Velkov

Monash University, Australia

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Zika is a newly emerged virus that has a grave potential to destabilize civil society as we know it. The World Health Organization (WHO) and National Center for Emerging and Zoonotic Infectious Diseases (CDC, USA), have both called for urgent action towards the development of anti-Zika therapeutics. Currently, there are no approved drugs and vaccines for human Zika virus infection. The development and deployment of a specific vaccine to control Zika virus infection is paramount. Zika is an arbovirus that is transmitted to humans in an enzootic cycle between Aedes mosquitoes (the epizootic vector) and amplifying vertebrae hosts, usually birds. The uncontrolled spread of Zika is a direct threat to Australia's biosecurity, economy and environment. Worryingly, there have been recent reports of infected individuals in Queensland, where Aedes aegypti mosquitoes are endemic. Our vaccine development approach employs recombinant Zika virus protein antigens that have been produced in a heterologous expression system. The success of this project should translate to immediate benefits on a global scale and importantly safeguard the global community and economy against this unchecked infectious disease.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectInfectious Diseases
  • SubjectVaccines & Immunisation
  • BylineArticles whose byline prints “Tony Velkov”